Novel Resistance Mechanisms to Osimertinib Analysed by Whole-Exome Sequencing in Non-Small Cell Lung Cancer

PURPOSE: Molecular-based targeted therapy has improved life expectancy for advanced non-small cell lung cancer (NSCLC). However, it does not have to be inevitable that patients receiving third-generation EGFR-TKIs become drug resistant. EGFR C797S and MET amplification are common mechanisms of osime...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhen, Zhao, Wei, Yang, Zhen, Wang, Yue Ming, Dai, Yu, Chen, Liang-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920504/
https://www.ncbi.nlm.nih.gov/pubmed/33658860
http://dx.doi.org/10.2147/CMAR.S292342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920504/
https://www.ncbi.nlm.nih.gov/pubmed/33658860
http://dx.doi.org/10.2147/CMAR.S292342

Ejemplares similares